Drug Shortage Report for TYPHIM VI

Last updated on 2021-04-02 History
Report ID 125784
Drug Identification Number 02130955
Brand name TYPHIM VI
Common or Proper name Salmonella typhi Vi Capsular Polysaccharide Vaccine
Company Name SANOFI PASTEUR LIMITED
Market Status MARKETED
Active Ingredient(s) SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE
Strength(s) 25MCG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 x 0.5 mL (single dose) syringe
ATC code J07AP
ATC description BACTERIAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-04-01
Actual start date 2021-04-01
Estimated end date 2021-04-01
Actual end date 2021-04-01
Shortage status Resolved
Updated date 2021-04-02
Company comments Sanofi Pasteur will be discontinuing the multidose vial presentation of Typhim Vi ® vaccine effective April 1st 2021. The single dose syringe presentation of Typhim Vi® will still be available to the market.
Health Canada comments
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 416-667-2611 or 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2779 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-04-02 English Compare
v5 2021-03-23 French Compare
v4 2021-03-23 English Compare
v3 2021-03-23 English Compare
v2 2020-10-06 French Compare
v1 2020-10-06 English Compare